Bronchiolitis and its Different Ways of Management in Raparin Teaching Hospital, Erbil-Iraq

Bronchiolitis and its Different Ways of Management in Raparin Teaching Hospital, Erbil-Iraq Sasan Loqa Hanna FIBMS-Ped, lecturer of Pediatrics, College of Medicine, HMU. Erbil-Iraq. Background: Despite the prevalence, global impact, financial burden, and mortality and morbidity related to bronchiolitis, clinical management still seems to be difficult. Objective: To describe the diversity of medical treatment options used to manage bronchiolitis and conclude the safest and most effective way to treat it in order to help the development of an evidence based treatment protocol at Raparin teaching hospital. Patients and Methods: This was randomized controlled trial conducted at the inpatient wards of Raparin teaching hospital in Erbil city-Iraq, during the period from 1st January to 1st August 2022. A total of 125 children aged one to 60 months presented with bronchiolitis were enrolled in the study and assigned into five groups (A, B, C, D and E), each of 25 cases. Results: There was non-significant statistical association between treatment groups and presence of wheeze after treatment (P = 0.538), while statistically significant association between various treatment modalities and cough after treatment (P=0.006) in the same way the association was significant with accessory muscle use after treatment (P=0.037). Conclusion: Generally patients in groups B (inhaled bronchodilator) and D (inhaled bronchodilator and intravenous steroids) had better response rates in terms of cough, accessory muscle use, respiratory rate (tachypnea), time to resolution of fever and coryza, duration of IV fluid therapy, oxygen therapy and hospital stay. Keywords: Bronchiolitis, Wheeze, Treatment, Randomized clinical trial, Iraq. DOI: 10.5281/zenodo.7178738Citation: Hanna S.L. Bronchiolitis and its Different Ways of Management in Raparin Teaching Hospital, Erbil-Iraq. AJMS 2022; 8 (4): 102-16. DOI: 10.5281/zenodo.717873